CytoMed Therapeutics (GDTC) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
GDTC is expected to report earnings to rise 33.33% to -3 cents per share on November 27
Q3'24
Est.
$-0.04
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.04
Q4'23
Est.
$-0.05
Q3'23
Beat
by $0.01
The last earnings report on September 30 showed earnings per share of -2 cents, beating the estimate of -3 cents. With 6.15K shares outstanding, the current market capitalization sits at 26.17M.